Bayesian Capital Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,013
| Closed | -$1.09M | – | 670 |
|
|
2024
Q2 | $1.09M | Buy |
+8,013
| New | +$1.09M | 0.13% | 209 |
|
|
2024
Q1 | – | Sell |
-5,561
| Closed | -$700K | – | 773 |
|
|
2023
Q4 | $700K | Buy |
5,561
+2,432
| +78% | +$306K | 0.07% | 311 |
|
|
2023
Q3 | $293K | Buy |
+3,129
| New | +$293K | 0.03% | 474 |
|
|
2023
Q1 | – | Sell |
-6,500
| Closed | -$794K | – | 770 |
|
|
2022
Q4 | $794K | Buy |
6,500
+600
| +10% | +$73.3K | 0.12% | 229 |
|
|
2022
Q3 | $609K | Buy |
5,900
+3,400
| +136% | +$351K | 0.12% | 238 |
|
|
2022
Q2 | $232K | Sell |
2,500
-3,135
| -56% | -$291K | 0.04% | 572 |
|
|
2022
Q1 | $661K | Buy |
+5,635
| New | +$661K | 0.1% | 302 |
|